Sherry Aulin

This profile gathers the share dealings of Sherry Aulin in Xenon Pharmaceuticals Inc. Over a trading history stretching from 3 June 2021 to 2 September 2022, the count stands at 8 filings.

On the market, this insider has only sold: 1 sale, €464k in total. Other entries cover 5 option exercises. Since January 2022: no purchases and 1 sale on the market.

The newest entry dates from 7 September 2022: a transaction, in Xenon Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.